1-7 of 7
Ichiro Kawashima
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 study of sequential administration of gilteritinib after MEC chemotherapy in Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia in adults: Japan adult leukemia study group (JALSG) RR-FLT3-AML220 study

Free
Yuichi Ishikawa, Takahiro Yamauchi, Masashi Sawa, Tomomi Toubai, Yuho Najima, Tetsuya Nishida, Ichiro Kawashima, Yuna Katsuoka, Kazutaka Ozeki, Kensuke Usuki, Toru Kiguchi, Takeshi Saito, Satoru Takada, Ko Fujimoto, Shinya Sato, Tomoya Maeda, Hisayuki Yokoyama, Hiroki Uchida, Takumi Lee, Takashi Ishida, Matsuo Yamamoto, Akiko Saito, Emiko Sakaida, Yoshinobu Maeda, Itaru Matsumura, Yasushi Miyazaki, Hitoshi Kiyoi
Journal: Blood
Blood (2025) 146 (Supplement 1): 998.
https://doi.org/10.1182/blood-2025-998
Published: 2025
Journal Articles

Golseek-1: A Phase 3, double-blind, randomized study of golcadomide (GOLCA), a potential, first-in-class, oral CELMoD™ agent, + R-CHOP vs placebo + R-CHOP in patients with previously untreated, high-risk, large B-cell lymphoma

Free
Theodoros Vassilakopoulos, Javier Munoz, Huiqiang Huang, Ichiro Kawashima, Sung Yong Oh, Wojciech Jurczak, Juan Miguel Bergua Burgues, Ou Bai, Alejandro Berkovits, Keshu Zhou, Marc Hoffmann, Jason Westin, Maria Bouzani, Michal Kwiatek, Tai-Chung Huang, Argyrios Gkasiamis, Arpankumar Patel, Floriane Boucaud, Adrien Petel, Serena Perna, Grzegorz Nowakowski
Journal: Blood
Blood (2025) 146 (Supplement 1): 3704.
https://doi.org/10.1182/blood-2025-3704
Published: 2025
Journal Articles

Magrolimab plus azacitidine vs physician’s choice for untreated TP53 -mutated acute myeloid leukemia: the ENHANCE-2 study

Open Access
Clinical Trials & Observations
Joshua F. Zeidner, David A. Sallman, Christian Récher, Naval G. Daver, Anskar Y. H. Leung, Devendra K. Hiwase, Marion Subklewe, Thomas Pabst, Pau Montesinos, Richard A. Larson, Lindsay Wilde, Anoop K. Enjeti, Ichiro Kawashima, Cristina Papayannidis, Jenny O’Nions, Lisa Johnson, Mei Dong, Julie Huang, Taravat Bagheri, Gal Hacohen Kleiman, Calvin Lee, Paresh Vyas
Journal: Blood
Blood (2025) 146 (5): 590–600.
https://doi.org/10.1182/blood.2024027408
Published: 2025
Includes: Supplemental data
Journal Articles

Metformin Suppresses Expression of Pre-Fibrotic Enzyme Lysyl-Oxidase Levels through Inhibition of UPR in MPN Cells

Free
Megumi Suzuki, MD, Ichiro Kawashima, Keita Kirito, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3070.
https://doi.org/10.1182/blood-2018-99-113276
Published: 2018
Journal Articles

Aberrant Activation of NF-κB and Hypoxia Enhances Glycolytic Enzyme Hexokinase II Expression in B-Cell Lymphoma through Activation of HIF-1

Free
Kei Nakajima, Keita Kirito, MD, Ichiro Kawashima, Megumi Koshiishi, Takuma Kumagai, Toru Mitsumori
Journal: Blood
Blood (2017) 130 (Supplement 1): 4025.
https://doi.org/10.1182/blood.V130.Suppl_1.4025.4025
Published: 2017
Journal Articles

Metformin Inhibits JAK2V617F Activity By Activating AMPK and PP2A Containing B56 Alpha Subunits in MPN Cells

Free
Ichiro Kawashima, MD, Keita Kirito, MD
Journal: Blood
Blood (2015) 126 (23): 1636.
https://doi.org/10.1182/blood.V126.23.1636.1636
Published: 2015
Journal Articles

Metformin Exerts Anti-Leukemic Effects Via Direct Inhibition Of Oncogenic Kinase Activity In Leukemia Cells Derived From Myeloproliferative Neoplasms

Free
Ichiro Kawashima, MD, Keita Kirito, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2853.
https://doi.org/10.1182/blood.V122.21.2853.2853
Published: 2013